The paper by Cho Kim et al shows a role for Wig1 in regulating p21 mRNA decay through RISC recruitment, and how as a consequence Wig1 regulates senescence. Overall the molecular mechanism described here by which Wig1 is regulating p21 is interesting and novel but the data clashes with previous observations of the Wikman lab that attribute the effects of Wig1 to regulation of the stability of p53 mRNAs. The authors compare the effects of Wig1 on p53 and p21 null background or upon p53 or p21 knockdown, and the results seems to suggest a direct effect on p21 regulation, although whether effects on p53 should be excluded it is not 100 % clear. The authors go into detailing how Wig1 interacts with the p21 mRNA and partially map the motifs and regions involved in the interaction, at the same time that suggesting how these affect miRNA regulation of p21. The relation with the miRNA machinery and how it blocks the control by microRNAs is one of the most novel points. Besides the clarification of the results with p21 and p53, the other part that is weaker is their characterization of the effects of Wig1 on senescence as the cells that they choose to use are not the best system to study senescence. Finally at the very end of the manuscript the authors choose to present some preliminary data on how Wig1 could be regulating additional mRNAs in a similar way. Although the data is interesting, in its current status is very preliminary and have it confined to a Supplementary table is far from ideal, I suggest that this data should be removed from the manuscript and used to build another story.
Thank you for submitting your manuscript for consideration by The EMBO Journal. We have now received the reports from three expert reviewers, which are copied below. These referees all express interest in your findings in principle, but also raise a number of substantive concerns that would need to be addressed before publication may be warranted. Should you be able to adequately answer and clarify these concerns, then we could consider a revised version of the manuscript further for publication. Of particular importance for such a revision will be to experimentally address the first two specific points of referee 1 and the one major concern of referee 2 regarding miR-106-p21UTR interaction; as well as the issues raised in points 2 and 8 of referee 3.
In this light, I am therefore inviting you to prepare a revised version of the manuscript in response to the referees' comments. In this respect, please be reminded that it is our policy to allow a single round of major revision only, and that it will therefore be important to diligently and comprehensively answer to all the specific points raised at this stage in the process. When preparing your letter of response to the referees' comments, please also bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time, and it is our policy that competing manuscripts published during this period will have no negative impact on our final assessment of your revised study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider this work, and please do not hesitate to contact me in case you should have any additional question regarding this decision or the reports. I look forward to your revision.
Yours sincerely, Editor The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
The paper by Cho Kim et al shows a role for Wig1 in regulating p21 mRNA decay through RISC recruitment, and how as a consequence Wig1 regulates senescence. Overall the molecular mechanism described here by which Wig1 is regulating p21 is interesting and novel but the data clashes with previous observations of the Wikman lab that attribute the effects of Wig1 to regulation of the stability of p53 mRNAs. The authors compare the effects of Wig1 on p53 and p21 null background or upon p53 or p21 knockdown, and the results seems to suggest a direct effect on p21 regulation, although whether effects on p53 should be excluded it is not 100 % clear. The authors go into detailing how Wig1 interacts with the p21 mRNA and partially map the motifs and regions involved in the interaction, at the same time that suggesting how these affect miRNA regulation of p21. The relation with the miRNA machinery and how it blocks the control by microRNAs is one of the most novel points. Besides the clarification of the results with p21 and p53, the other part that is weaker is their characterization of the effects of Wig1 on senescence as the cells that they choose to use are not the best system to study senescence. Finally at the very end of the manuscript the authors choose to present some preliminary data on how Wig1 could be regulating additional mRNAs in a similar way. Although the data is interesting, in its current status is very preliminary and have it confined to a Supplementary table is far from ideal, I suggest that this data should be removed from the manuscript and used to build another story.
Specific comments:
-Cancer cell lines from different tissues (MCF7, 293T, H460, ,...) are used in this study. The senescence experiments should be performed in primary cells (such as human normal fibroblasts) and the rationale for choosing a tissue or another should be given.
-The majority of the paper is based on the use of one siRNA against Wig1. Although a few evidences are also given with two independent siWig1 in Figure S1 , the impact of Wig1 on cell proliferation should be investigated by stable knock down (shRNA) and overexpression of Wig1. Specifically, the effect of Wig1 is being assessed by monitoring cell proliferation only for 4 days in a cell population only partially transfected with siWig1. In these conditions, cells are still proliferating (even if slower) and this phenotype cannot be called senescence at this stage. The longterm effect of Wig1 on cell proliferation needs to be assessed.
-To strenghten the characterization of the phenotype induced by siWig1, a proliferation marker such as Ki67 staining or BrdU incorporation should be analysed.
-Is Wig1 expression changing during cellular senescence? -In the siRNA experiments in Figures 2A-C , some controls are lacking and need to be shown: Con si followed by Wig1 si and Wig1 si followed by p53 si.
-In the description of Figure 2 , although most of the effect of Wig1 si on cell proliferation seems to be p53-independent, this is not correct to state that "the absence of p53 did not affect Wig1 depletion-mediated premature senescence" as the analysis of cell number (2B, E) and SA-Beta-Gal (2C, F) both show a reduced propensity of Wig1 si to induce senescence in a p53-depleted background.
-There is a discrepancy between the p21 mRNA level observed when overexpressing Wig1 in Figure 3E (2-fold decrease) and Figures 4A and B (no difference observed "before IP"). In Figures  4A and B, the 2-fold serial dilutions on the left show what a 2-fold downregulation of the p21 mRNA level would be. In the same line, at the protein level, p21 level is decreased when overexpressing FLAG-Wig1 in Figure 3E but not in Figure S7B .
-In Figure 4D , give details explaining why the Wig1 rabbit polyclonal antibody does not recognise overexpressed FLAG-Wig1 but only endogenous Wig1.
-In Figure 4D and E, the effect of Wig1 mutants on p21 level is assessed. Their binding capacity to p21 mRNA 3'UTR needs to be tested by RNP-IP before concluding that "Wig1 physically interacts with the 3'UTR of p21 via its ZF1 and ZF2 domains".
-In Figure 5B , overexpressed Ago2 interacts with Wig1 in an RNAse insensitive-manner, correct "endogenous" in the text.
-The p21 mRNA level should be quantified by qRT-PCR in all the panels of Figures 4 and 5 as done in Figure 4D to clearly see the effect of Wig1 and Ago2.
-In Figure 6C , anti-miRs or mutated miRs should be used together with Wig1 overexpression.
-In Figure 6F , the FL-p21 3'UTR mRNA/RL mRNA ratios should all be normalized to the one of pFL-EV with Con si.
Minor comments:
The writing of the manuscript needs some corrections to make it more readable and correct Referee #2 (Remarks to the Author):
The manuscript by Kim and coworkers show that the RNA-binding protein Wig1 is growthstimulatory and inhibits cellular senescence in a manner dependent on the reduction of p21 levels. The authors further show that p21 expression is inhibited by a Wig1-enhanced p21 mRNA decay and this process involves the recruitment by Wig1 of RISC-Ago2-miR-106 complex to the p21 mRNA.
This interesting report contributes to a growing body of evidence that RBPs and microRNAs corregulate shared target mRNAs. In the present manuscript, Wig1 promotes the recruitment of the miR-RISC complex to the p21 3'-untranslated region (UTR), and this regulation is presented in the context of tumorigenesis. The report is nicely written and assembled, and the authors have provided extensive data to support their model. However, some additional information is needed: I am concerned that the authors do not show that Wig1 affects the interaction of miR-106 with the p21 mRNA. Since this is a central aspect of the authors' conclusions, they must test this directly by tagging the p21 3'-UTR and measuring the association of miR-106 as a function of Wig1 abundance.
Minor comments 1) remove the shadows in some figures 2) please note that it is 'tristetraprolin', not 'tristetraproline' 3) I am curious whether HuR, which binds the p21 3'UTR proximal to the coding region, competes with Wig1 for interaction with this RNA region. This might explain why HuR promotes p21 mRNA stability while Wig1 promotes p21 mRNA decay.-Referee #3 (Remarks to the Author):
The authors show that the RNA binding protein Wig1 regulates p21 mRNA stability. Wig1 binding to a stem-loop structure in the 3'UTR of p21 mRNA allows nearby miRNA-mediated silencing.
1. Wig1's official name is ZMAT3.
2. The authors show that Wig1 depletion causes senescence. Indeed, in some tumours Wig1 levels are high and there is an apparent negative correlation between its expression and p21 mRNA (Fig.  7) . This may suggest that high levels of Wig1 lower p21 to allow bypass of senescence. Therefore, the authors should show that indeed high levels of Wig1 is able to bypasses senescence which is, for example, induced by oncogene expression. In this experiment they should also include Wig1-mut2 to show that the zinc-fingers are required.
3. Fig. 1 : The authors should show that the effect of Wig1 knockdown can be rescued by the expression of a siRNA-resistant Wig1.
4. Fig. 1 : Total Rb levels should be included in the westerns presented in (F) and (G) to be able to conclude that Wig1 knockdown indeed results in hypophosphorylated Rb.
5. Figure 2A should also show, for completeness, phospho-Rb and total Rb levels. 6. Fig. 4 . The authors should provide direct evidence that the ZF mutant is not binding to the p21 3'UTR (especially to region F1, figure 3E ).
7. Quantification of western blots is required for figure 6B and 6C.
8. What determines specificity for miR-106 sites in the 3'UTR of p21? Is there a consensus sequence for binding? The authors may mind their RNP-IP microarray data to find a consensus sequence or structure motif in the 3'UTRs bound by WIG1.
9. Wig1 stabilizes p53 by binding to its mRNA (Vilborg et al., PNAS 2009 ). Wig1 depletion resulted in decreased p53 protein levels in U2OS cells. However, the authors here observed no change in p53 protein levels in the same cell line (Fig. S2 ). The authors should refer to this discrepancy and clarify it.
10. In the tumors presented in figure 7 I miss the annotation to the status of p53. One would expect that the tumors with high Wig1 levels and low p21mRNA are p53 wildtype.
11. Wig1 is highly induced by p53. Is the role played by Wig1 under this conditions related to the function they observed here, meaning to help restricting p21 levels? Figure S4 . Thus, these results demonstrate that Wig1 depletion also results in premature senescence phenotypes with p21 induction in primary cells. As described in the Introduction, premature senescence is thought to be a key strategy for the suppression of carcinogenesis. Our long-term research goal is to apply our understanding of premature senescence to cancer treatment. Thus, we studied premature senescence in cancer cell lines from different tissues. In this study, we mainly conducted experiments in the human breast cancer cell line, MCF7 (Fig.1-Fig. 6 ). To explore the generalizability of this effect of Wig1 depletion on various cell lines, we used H460 lung carcinoma, U2OS osteosarcoma, and MCF10A normal mammary epithelial cell lines ( Supplementary Fig S3) . To perform these experiments on a p53 -/-or p21 -/-genetic background, we used the HCT116 colon cancer cell line (Figure 2 ). We used the human embryonic kidney (HEK) 293T cell line in some reporter assay experiments because 293T cells are easily transfected with high efficiency (>90%) as described in Kumar et al. [Oncogene 30:843-853 (2011)] . As therapeutic application is the ultimate goal of this study, we demonstrated a role of Wig1 in premature senescence in several cancer cell lines from different tissues. We provided this rationale for use of cancer cell lines from different tissues, such as breast, lung, and colon, in the Discussion section.
COMMENT 2: The majority of the paper is based on the use of one siRNA against Wig1. Although a few evidences are also given with two independent siWig1 in Figure S1, ANSWER 2: We agree with the reviewer's comment; however, since Wig1 knockdown induces premature senescence and prevents cell proliferation, stable Wig1 knockdown in cultured cells is not feasible. Thus, in order to assess the long-term effect of Wig1 depletion, we observed the impact of Wig1 on cell proliferation for up to 10 days after Wig1 Si transfection. As shown in Supplementary Figure S1 , cells did not proliferate and exhibited premature senescence phenotypes for up to 10 days after Wig Si transfection. We did try to investigate the impact of Wig1 in cells that stably overexpressed Wig1. To generate these cells, we transfected the pCMV-Wig1 DNA construct into MCF7, U2OS, and HCT116 cancer cells and selected cells that stably overexpressed Wig1 with G418. We were unable to generate MCF7 cells that stably overexpressed Wig1, although we achieved stable overexpression of Wig1 in U2OS and HCT116 cells. As shown in the Figure R1 , p21 levels were decreased in both Wig1-overexpressing U2OS and HCT116 cells. The cell morphology and the cell proliferation were not significantly affected in these cells. Treatment of these stably transfected cells with doxorubicin as an apoptotic stimulus, sensitivity to apoptotic stimulus was increased in both cell types. It has been reported that inactivation of p21 or loss of p21 sensitizes cells to apoptosis [Hemmati et al. Oncogene 24:4114-4128 (2005) Figure S13 , young HDF (Passage 11) did not exhibit SA-β-Gal positivity, while mid-old (Passage 25) and old (Passage 36) HDF showed a moderate and high levels of SA-β-Gal positivity, respectively. The levels of Wig1 and p21 in cellular senescence were not altered among young, mid-old, and old HDF; the levels of phosphopRb and p53 in HDF were clearly decreased during cellular senescence of HDF primary cells. As a reference, we compared the relative levels of Wig1, p53, p21, and phospho-Rb between MCF7 cancer cells and HDF primary cells in the same gel as shown in Supplementary Figure S13. Figures 2A-C , some controls are lacking and need to be shown: Con si followed by Wig1 si and Wig1 si followed by p53 si.
COMMENT 5: In the siRNA experiments in
ANSWER 5: We altered Fig. 2A-2C to include new data including the requested controls, Con Si followed by Wig Si and Wig1 Si followed by p53 Si.
COMMENT 6: In the description of Figure 2, although most of the effect of Wig1 si on cell proliferation seems to be p53-independent, this is not correct to state that "the absence of p53 did not affect Wig1 depletion-mediated premature senescence" as the analysis of cell number (2B, E) and SA-Beta-Gal (2C, F) both show a reduced propensity of Wig1 si to induce senescence in a p53-depleted background.
ANSWER 6: We agree with the reviewer's comment. The absence of p53 resulted in a reduced propensity of Wig1 Si to induce senescence due to a decrease in p21 basal levels. We corrected the text to state "In the absence of p53, however, Wig1 depletion-mediated premature senescence was lessened due to a decreased level of p21 as compared to cells with intact p53 (Figure 2 )." Figure 3E but not in Figure S7B .
COMMENT 7: There is a discrepancy between the p21 mRNA level observed when overexpressing Wig1 in Figure 3E (2-fold decrease) and Figures 4A and B (no difference observed "before IP"). In Figures 4A and B, the 2-fold serial dilutions on the left show what a 2-fold downregulation of the p21 mRNA level would be. In the same line, at the protein level, p21 level is decreased when overexpressing FLAG-Wig1 in
ANSWER 7: We agree with the reviewer's points. Our data in Figure 4A , 4B, and S7B only show trends and are not as dramatic as in Figure 3E . We repeated the experiments and replaced Figure 4A , 4B, and S14B (S7B in original manuscript) to include new data including quantitation. Figure 4D , give details explaining why the Wig1 rabbit polyclonal antibody does not recognise overexpressed FLAG-Wig1 but only endogenous Wig1. ANSWER 8: We detected overexpressed Flag-Wig1 with the anti-Flag antibody. We cut the nitrocellulose membrane to detect endogenous Wig 1 with an anti-Wig1 antibody and the loading control with an anti-actin antibody in the same gel. In response to the reviewer's question, we repeated the experiment to show both endogenous Wig1 and overexpressed Flag-Wig1 on the same gel with the anti-Wig1 antibody. The Wig1 rabbit polyclonal antibody recognized overexpressed Flag-Wig1, and thus, we replaced Figure 4D with this new data showing endogenous Wig1 and overexpressed Flag-Wig1 on the same gel. Figure 4D and E, the effect of Wig1 mutants on p21 level is assessed. Their binding capacity to p21 mRNA 3'UTR needs to be tested by RNP-IP before concluding that "Wig1 physically interacts with the 3'UTR of p21 via its ZF1 and ZF2 domains". ANSWER 9: We appreciate reviewer's critical comments. Since an other reviewer also wanted to clarify this point with fragment 1 (F1) of p21 mRNA, we performed RNP-IP experiments with Wig1 wt, Wig1 mut1 containing ZF1 and ZF2, and Wig1 mut2 containing ZF3 together with F1. Wig wt and Wig mut1 physically associated with F1 of p21 mRNA, while Wig1 mut2 did not. These new data were added as Figure 6G (as we first showed the F1 fragment data in Figure 6E and 6F) and were described in the Results section. In addition, we also tested the binding capacity of Wig1 mutants to Ago2 protein and found that Ago2 was also associated with Wig1-wt and Wig1-mut1 but not with Wig1-mut2. These data were added as Figure 5D (previous Figure 5D -5G changed to Figure 5E -5H). Altogether, our results support the conclusion that Wig1 may regulate p21 mRNA decay via its ZF1 and ZF2 domains.
COMMENT 8: In

COMMENT 9: In
COMMENT 10: In Figure 5B , overexpressed Ago2 interacts with Wig1 in an RNAse insensitivemanner, correct "endogenous" in the text.
ANSWER 10: We corrected "endogenous" to "overexpressed" in the text. Figure 4D to clearly see the effect of Wig1 and Ago2.
COMMENT 11: The p21 mRNA level should be quantified by qRT-PCR in all the panels of Figures 4 and 5 as done in
ANSWER 11: Figure 4D includes data from quantitative RT-PCR (qRT-PCR), and Fig 4A, 4B, 5E , 5G, 6E, and new Fig 6G include data from radioisotope-PCR (RI-PCR). In qRT-PCR analysis, target cDNA and internal control (RLuc) were amplified in separate tubes and quantified by their relative values as shown in Figure 4D ; however, RI-PCR is performed in a single tube to amplify both target and internal control, so the results are more accurate and unbiased. RI-PCR data can be quantitatively analyzed as "Before-IP" data and qualitatively analyzed as "After-IP" data as shown in a previous report by Kim et al. [Cell 120:195-208 (2005) ]. Thus, we quantified the "Before-IP" data in all panels of Figures 4, 5, 6E, and the new Fig 6G. Since no internal control was included, data in the panel of "After-IP" in all RI-PCR results could not be quantified. Figure 6C , anti-miRs or mutated miRs should be used together with Wig1 overexpression.
COMMENT 12: In
ANSWER 12: We appreciate this valuable comment. We conducted experiments with anti-miRs and together with Wig1 overexpression. In the presence of anti-miRs, Wig1 overexpression did not affect p21 mRNA and protein levels as shown in the newly added Supplementary Figure S7 . These data indicate that miRs are required for Wig1-mediated p21 regulation. As we already demonstrated in Figure 6B and 6C, Wig1 and miRs are critical for the regulation of p21. Figure 6F , the FL-p21 3'UTR mRNA/RL mRNA ratios should all be normalized to the one of pFL-EV with Con si.
COMMENT 13: In
ANSWER 13: We normalized the FL-p21 3'UTR mRNA/RL mRNA ratios to Con Si.
Minor comments:
COMMENT 14: The writing of the manuscript needs some corrections to make it more readable and correct ANSWER 14: We obtained editing of our revised manuscript by a professional scientific editing company (www.biosciencewirters.com) in USA again. We hope that these revisions rendered our manuscript more readable.
Referee #2 (Remarks to the Author):
This interesting report contributes to a growing body of evidence that RBPs and microRNAs corregulate shared target mRNAs. In the present manuscript, Wig1 promotes the recruitment of the miR-RISC complex to the p21 3'-untranslated region (UTR), and this regulation is presented in the context of tumorigenesis. The report is nicely written and assembled, and the authors have provided extensive data to support their model. However, some additional information is needed: COMMENT 1: I am concerned that the authors do not show that Wig1 affects the interaction of miR-106 with the p21 mRNA. Since this is a central aspect of the authors' conclusions, they must test this directly by tagging the p21 3'-UTR and measuring the association of miR-106 as a function of Wig1 abundance.
ANSWER 1: We appreciate the reviewer's valuable comment. As the reviewer requested, we tested whether Wig1 affects the interaction between miR-106b and the p21 mRNA 3'UTR. We precipitated biotinylated miR-106b with streptavidin-conjugated beads and analyzed the p21 3'UTR reporter in the presence or absence of Wig1 using RI-PCR technique. Whereas miR-106b bound to p21 mRNA 3'UTR in the presence of Wig1, miR-106b failed to bind to p21 mRNA 3'UTR in the absence of Wig1. The data were added as Figure 6D . (Original Figures 6D-6G were moved to Figures 6E-6H ). In addition, we conducted an experiment to clarify whether miR-106b binds to RISC in the absence of Wig1. We demonstrated that miR-106b in Ago2 immunoprecipitate in Wig1-depleted cells (Supplementary Figure S8) . Altogether, these results support our conclusion that Wig1 plays a critical role in the recruitment of RISC to target p21 mRNA.
Minor comments COMMENT 2: remove the shadows in some figures
ANSWER 2: We removed the shadows from all figures.
COMMENT 3: please note that it is 'tristetraprolin', not 'tristetraproline'
ANSWER 3: We corrected this in the manuscript.
COMMENT 4: I am curious whether HuR, which binds the p21 3'UTR proximal to the coding region, competes with Wig1 for interaction with this RNA region. This might explain why HuR promotes p21 mRNA stability while Wig1 promotes p21 mRNA decay.
ANSWER 4: Wang et al. [Mol Cell Biol 20:760-769 (2000) ] reported that HuR plays a major role in regulating stress-induced p21 expression by enhancing p21 mRNA stability. Giles et al. [J Biol Chem 278:2937 -2946 (2003 ], however, reported that although HuR binds to multiple 3'UTR ciselements of p21 mRNA, this factor does not appear to be a major modulator of p21 expression or growth inhibition in MDA-468 breast cancer cells. Recently, HuR-dependent RISC loading to the target mRNA was found to control mRNA decay [Glorian et al. Cell Death Differ 18:1692 -1701 (2011 ], while HuR attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA [Kundu et al. Nucleic Acids Res 40:5088-5100 (2012) ]. Thus, HuR function is somewhat controversial. When we examined the HuR-binding core sequence AUUUA of ARE in p21 mRNA 3'UTR (109 ~113, 176~180, and 248~252; Numbering is relative to the first nucleotide following the termination codon, which is defined as 1), we found that it does not overlap with the putative Wig1-binding site near the miR-106b-or let-7a-binding sites ( Figure 6A ). We could not exclude the possibility that HuR binding affords steric hindrance to Wig1 binding on p21 mRNA. It would be interesting to determine whether HuR promotes p21 mRNA stability while Wig1 promotes p21 mRNA decay. We think this interesting project is beyond the scope of this study but may pursue this avenue in the future.
Referee #3 (Remarks to the Author):
The ANSWER 2: It has been reported that oncogene-induced premature senescence is associated with accumulation of p16 [Serrano et al. Cell 88:593-602 (1997) ]. Ras-induced senescence has been characterized by p16 overexpression [Bennecke et al. Cancer Cell 18:135-146 (2010) ]. In addition, only loss of p16 weakens Ras-induced senescence, and the ability of p16 to inhibit CDK and DNA replication is not shared by p21 [Haferkamp et al. Aging 1:542-556 (2009)] . We also published data showing p16 accumulation in Ras-induced senescence [Byun et al. Cancer Res 69: 4638-4637 (2009)] . To ensure that p21 is not a critical player in oncogene-induced senescence, we examined the change of p21 levels in Ras-induced premature senescence. We observed that p16, but not p21, was induced in oncogene-induced senescence (see Figure R2A) . Thus, we conclude that oncogeneinduced senescence is not the proper system to determine whether high levels of Wig1 lower p21 to allow bypass of senescence. Thus, we chose to use a low concentration of the stressor doxorubicin (30 ng/ml) to examine stress-induced premature senescence as described in our previous work [Cancer Res 69: 4638-4637 (2009)] and work from other groups [Chang et al. Oncogene 18:4808-4818 (1999); Roninson. Cancer Res 63:2705 -2715 (2003 ]. Upon doxorubicin-induced activation of p53/p21 signaling pathway in the presence of p53, overexpressed Wig1 wt could not decrease p21 level as low as basal level and failed to bypass doxorubicin-induced premature senescence (see Figure R2B ). Next, we tested whether high levels of Wig1 to lower p21 would allow bypass of senescence in the absence of p53. In HCT116 p53-/-cells, low levels of p21 induced by a p53-independent pathway were decreased due to Wig1-wt overexpression, while these effects were not observed following Wig1-mut2 overexpression (see Figure R2B ). We observed that HCT116 p53-/-cells that overexpress Wig1-wt altered the final cell fate from a premature senescence to an apoptosis phenotype, which was evidenced by PI positivity and cleaved PARP (see Figure R2B -b and c). We recently reported that cellular context could switch cell fate between premature senescence and apoptosis [Cell Death Differ 18: 666-677 (2011) ]. This phenomenon could be explained with feedforward loop which was described in the final paragraph in the Discussion section. Furthermore, these data were also described in response to Comment 11 as follows. We think that such a fine-tuning mechanism is inadequate to prevent stress-induced premature senescence. We suggest that Wig1 plays an important role in maintaining low basal p21 levels to prevent the onset of senescence in unstressed condition; however, if highly activated p53 induces a large amount of p21 transcript, Wig1 alone is unable to downregulate this increased p21 transcript to levels similar to basal levels (Supplementary Figure S12 in the revised manuscript) . Thus, we suggest that such negative transcription co-regulation circuits may be important to provide finetuning and maintenance of protein steady-state.
3:e298 (2012)] very recently proposed that ARE may be a putative Wig1 target motif. Based on our results regarding the 3'UTR analysis of novel Wig1 target mRNAs (as shown in Table S1 of original manuscript), some of the putative targets (such as C2CD4C and KRTAP10-12) do not have ARE. We totally agree that this is an important issue; however, we are not able to address the reviewer's question at this moment. The other reviewer suggested that the data regarding ACOT7 and ANKRD11 should be removed and should be used to build another story, as it is preliminary. Since we deleted the data from the RNP-IP microarray analysis from the revised manuscript, the issue regarding consensus sequences or structure motifs in the 3'UTRs bound by Wig1 will be a focus of our next project.
COMMENT 9: Wig1 stabilizes p53 by binding to its mRNA (Vilborg et al., PNAS 2009 ). Wig1 depletion resulted in decreased p53 protein levels in U2OS cells. However, the authors here observed no change in p53 protein levels in the same cell line (Fig. S2) . The authors should refer to this discrepancy and clarify it. ANSWER 9: We examined the p53 mRNA levels in the presence and absence of Wig1 in not only U2OS cells but also MCF7 cells, as shown in the newly added Supplementary Figure S11 . We also showed that p53 protein levels were not affected by either Wig1 presence or absence in several different cell lines in original manuscript. Despite repeating the experiments independently several times, we did not observe an changes in p53 levels due to Wig1 in the same cell line (U2OS) that was used by Vilborg et al. [PNAS 106:15756-15761 (2009) ]. The lack of relationship between Wig1 and p53 levels recently reported by Sedaghat et al. [PLoS One 7:e29429 (2012) ] was consistent with our results [See Figure 4 in the paper reported by Sedaghat et al. (2012) ]. These investigators also did not observe an increase or decrease in p53 levels following treatment of cells with a Wig1 antisense oligonucleotide. We also discussed this discrepancy in the Discussion section and referred to the paper by Sedaghat et al. (2012) . ANSWER 10: Since we had only RNA sample from the tissues, we conducted RT-PCR and sequencing of hot spots at amino acid positions 175, 248, and 273 in the DNA-binding domain of p53 on the samples from 33 lung cancer patients. These residues are known as the most frequently mutated sites in various cancers including lung cancers (Lasky and Silbergeld. Environ Health Perspect 104:1324 -1331 (1996 ; Behn et al. Clin Cancer Res 4:361-371 (1998); Ye et al. Genet Mol Res 8:1509 -1518 (2009 . The correlation between Wig1 and p21 mRNAs in p53 wildtype versus p53 mutant was assessed as shown below (see Table R1 and Figure R4 ). We did not observe a correlation between Wig1 mRNA or p21 mRNA and p53 status.
COMMENT 11: Wig1 is highly induced by p53. Is the role played by Wig1 under this conditions related to the function they observed here, meaning to help restricting p21 levels? ANSWER 11: We described an miRNA-mediated feedforward loop in the Discussion section of the original manuscript. We suggest such negative transcriptional co-regulation circuits may be important to provide fine-tuning and maintenance of the protein steady-state [Tsang et al. Mol Cell 26:753-767 (2007) ]. Under normal conditions, the basal level of Wig1 functions to regulate p21 levels to prevent the onset of cellular senescence. Under stressed conditions, p53-induced Wig1 plays a guardian role to finely regulate the induced p21 levels (Supplementary Figure S7 in original manuscript. It was renumbered as Supplementary Figure S12 in the revised manuscript). We think that such a fine-tuning mechanism is inadequate to prevent stress-induced premature senescence. We suggest that Wig1 plays an important role in maintaining low basal p21 levels to prevent the onset of senescence; however, if highly activated p53 induces a large amount of p21 transcript, Wig1 alone is unable to downregulate this increased p21 transcript to levels similar to basal levels (Supplementary Figure S12 in the revised manuscript) . Thus, we suggest that such negative transcription co-regulation circuits may be important to provide fine-tuning and maintenance of protein steady-state. Based on our results, Wig1 may be the first protein identified to play a role to
